Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17289902rdf:typepubmed:Citationlld:pubmed
pubmed-article:17289902lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:17289902lifeskim:mentionsumls-concept:C0026764lld:lifeskim
pubmed-article:17289902lifeskim:mentionsumls-concept:C1332717lld:lifeskim
pubmed-article:17289902lifeskim:mentionsumls-concept:C1706438lld:lifeskim
pubmed-article:17289902lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:17289902lifeskim:mentionsumls-concept:C0085358lld:lifeskim
pubmed-article:17289902lifeskim:mentionsumls-concept:C1413244lld:lifeskim
pubmed-article:17289902lifeskim:mentionsumls-concept:C2698600lld:lifeskim
pubmed-article:17289902lifeskim:mentionsumls-concept:C0205332lld:lifeskim
pubmed-article:17289902lifeskim:mentionsumls-concept:C1515097lld:lifeskim
pubmed-article:17289902pubmed:issue3lld:pubmed
pubmed-article:17289902pubmed:dateCreated2007-2-9lld:pubmed
pubmed-article:17289902pubmed:abstractTextSurvivin is a member of the inhibitors of apoptosis family and is overexpressed in different types of malignancies. Cytotoxic T cells recognizing survivin epitopes can be elicited in vitro and by vaccination in patients with leukemia, breast cancer, and melanoma. We did this study to investigate whether survivin-specific CD8+ T cells occur in patients with multiple myeloma.lld:pubmed
pubmed-article:17289902pubmed:languageenglld:pubmed
pubmed-article:17289902pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17289902pubmed:citationSubsetIMlld:pubmed
pubmed-article:17289902pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17289902pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17289902pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17289902pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17289902pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17289902pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17289902pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17289902pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17289902pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17289902pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17289902pubmed:statusMEDLINElld:pubmed
pubmed-article:17289902pubmed:monthFeblld:pubmed
pubmed-article:17289902pubmed:issn1078-0432lld:pubmed
pubmed-article:17289902pubmed:authorpubmed-author:AndreesenRein...lld:pubmed
pubmed-article:17289902pubmed:authorpubmed-author:MackensenAndr...lld:pubmed
pubmed-article:17289902pubmed:authorpubmed-author:HollerErnstElld:pubmed
pubmed-article:17289902pubmed:authorpubmed-author:RezvaniKatayo...lld:pubmed
pubmed-article:17289902pubmed:authorpubmed-author:GrubeMatthias...lld:pubmed
pubmed-article:17289902pubmed:authorpubmed-author:ObermannEllen...lld:pubmed
pubmed-article:17289902pubmed:authorpubmed-author:MoritzStephan...lld:pubmed
pubmed-article:17289902pubmed:issnTypePrintlld:pubmed
pubmed-article:17289902pubmed:day1lld:pubmed
pubmed-article:17289902pubmed:volume13lld:pubmed
pubmed-article:17289902pubmed:ownerNLMlld:pubmed
pubmed-article:17289902pubmed:authorsCompleteYlld:pubmed
pubmed-article:17289902pubmed:pagination1053-60lld:pubmed
pubmed-article:17289902pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:17289902pubmed:meshHeadingpubmed-meshheading:17289902...lld:pubmed
pubmed-article:17289902pubmed:meshHeadingpubmed-meshheading:17289902...lld:pubmed
pubmed-article:17289902pubmed:meshHeadingpubmed-meshheading:17289902...lld:pubmed
pubmed-article:17289902pubmed:meshHeadingpubmed-meshheading:17289902...lld:pubmed
pubmed-article:17289902pubmed:meshHeadingpubmed-meshheading:17289902...lld:pubmed
pubmed-article:17289902pubmed:meshHeadingpubmed-meshheading:17289902...lld:pubmed
pubmed-article:17289902pubmed:meshHeadingpubmed-meshheading:17289902...lld:pubmed
pubmed-article:17289902pubmed:meshHeadingpubmed-meshheading:17289902...lld:pubmed
pubmed-article:17289902pubmed:meshHeadingpubmed-meshheading:17289902...lld:pubmed
pubmed-article:17289902pubmed:meshHeadingpubmed-meshheading:17289902...lld:pubmed
pubmed-article:17289902pubmed:meshHeadingpubmed-meshheading:17289902...lld:pubmed
pubmed-article:17289902pubmed:meshHeadingpubmed-meshheading:17289902...lld:pubmed
pubmed-article:17289902pubmed:meshHeadingpubmed-meshheading:17289902...lld:pubmed
pubmed-article:17289902pubmed:meshHeadingpubmed-meshheading:17289902...lld:pubmed
pubmed-article:17289902pubmed:meshHeadingpubmed-meshheading:17289902...lld:pubmed
pubmed-article:17289902pubmed:meshHeadingpubmed-meshheading:17289902...lld:pubmed
pubmed-article:17289902pubmed:meshHeadingpubmed-meshheading:17289902...lld:pubmed
pubmed-article:17289902pubmed:meshHeadingpubmed-meshheading:17289902...lld:pubmed
pubmed-article:17289902pubmed:year2007lld:pubmed
pubmed-article:17289902pubmed:articleTitleCD8+ T cells reactive to survivin antigen in patients with multiple myeloma.lld:pubmed
pubmed-article:17289902pubmed:affiliationDepartment of Hematology and Oncology, Institute of Pathology, University of Regensburg, Regensburg, Germany. matthias.grube@klinik.uni-regensburg.delld:pubmed
pubmed-article:17289902pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17289902pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:332entrezgene:pubmedpubmed-article:17289902lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:17289902lld:entrezgene
lhgdn:association:35268lhgdn:found_inpubmed-article:17289902lld:lhgdn
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17289902lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17289902lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17289902lld:pubmed